Dubourg O, Azzedine H, Verny C, Durosier G, Birouk N, Gouider R, Salih M, Bouhouche A, Thiam A, Grid D, Mayer M, Ruberg M, Tazir M, Brice A, LeGuern E
INSERM U679 (ex U289), la Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
Neuromolecular Med. 2006;8(1-2):75-86. doi: 10.1385/nmm:8:1-2:75.
Autosomal-recessive forms of Charcot-Marie-Tooth (ARCMT) account for less than 10% of the families in the European CMT population but are more frequent in the Mediterranean basin and the Middle East because of more widespread consanguinity. Until now, demyelinating ARCMT was more extensively studied at the genetic level than the axonal form. Since 1999, the number of localized or identified genes responsible for demyelinating ARCMT has greatly increased. Eight genes, EGR2, GDAP1, KIAA1985, MTMR2, MTMR13, NDRG1, PRX, and CTDP1, have been identified and two new loci mapped to chromosomes 10q23 and 12p11-q13. In this review, we will focus on the particular clinical and/or neuropathological features of the phenotype caused by mutations in each of these genes, which might guide molecular diagnosis.
常染色体隐性遗传性夏科-马里-图思病(ARCMT)在欧洲夏科-马里-图思病患者群体中所占家庭比例不到10%,但在地中海盆地和中东地区更为常见,因为近亲结婚更为普遍。到目前为止,与轴索性相比,脱髓鞘性ARCMT在基因层面上得到了更广泛的研究。自1999年以来,导致脱髓鞘性ARCMT的定位或已确定基因的数量大幅增加。已确定了八个基因,即EGR2、GDAP1、KIAA1985、MTMR2、MTMR13、NDRG1、PRX和CTDP1,并将两个新的基因座定位到染色体10q23和12p11-q13。在本综述中,我们将重点关注由这些基因中每个基因的突变所导致的表型的特定临床和/或神经病理学特征,这可能会指导分子诊断。